{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:27:39Z","timestamp":1787768859244,"version":"build-2784847793"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.euroneuro.2014.06.009","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T22:18:22Z","timestamp":1403907502000},"page":"176-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale"],"prefix":"10.1016","volume":"25","author":[{"given":"Richard S.E.","family":"Keefe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki G.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan B.","family":"Spagnola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Dgetluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Ruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2014.06.009_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/schbul\/sbn163","article-title":"Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting","volume":"35","author":"Barch","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/schbul\/sbl035","article-title":"Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop","volume":"33","author":"Bellack","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jpsychires.2006.08.003","article-title":"Self-assessment of functional status in schizophrenia","volume":"41","author":"Bowie","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/schbul\/sbi020","article-title":"A summary of the FDA-NIMH-MATRICS workshop on clinical trial designs for neurocognitive drugs for schizophrenia","volume":"31","author":"Buchanan","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/schbul\/sbq038","article-title":"The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later?","volume":"37","author":"Buchanan","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.schres.2013.02.026","article-title":"Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia","volume":"146","author":"Burton","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1037\/h0034541","article-title":"Problems in the measurement of cognitive deficit","volume":"79","author":"Chapman","year":"1973","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2006.03.003","article-title":"A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis","volume":"85","author":"Dickinson","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1176\/appi.ajp.2007.07010089","article-title":"Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS psychometric and standardization study","volume":"165","author":"Green","year":"2008","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1176\/appi.ajp.2010.10030414","article-title":"Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia","volume":"168","author":"Green","year":"2011","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.schres.2011.01.004","article-title":"Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone","volume":"127","author":"Harvey","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib12","unstructured":"Hilt, D.C., 2011. EVP-6124, an Alpha-7 Nicotinic partial agonist, produces positive effects on cognition, clinical function, and negative symptoms in patients with chronic schizophrenia on stable antipsychotic therapy. In: Proceedings of the Poster presentation at the 50th Annual ACNP Meeting, Hollywood, FL, December 4\u20138."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib13","unstructured":"Keefe, R.S.E., 2014. Sharpening the signal in cognitive enhancement trials. In: Proceedings of the Symposia presented at the 4th Annual SIRS Meeting,Florence, Italy, April 5\u20139."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1176\/appi.ajp.163.3.426","article-title":"The Schizophrenia Cognition Rating Scale (SCoRS): interview-based assessment and its relationship to cognition, real-world functioning and functional capacity","volume":"163","author":"Keefe","year":"2006","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3346\/jkms.2010.25.2.276","article-title":"Factor structure of the neurocognitive tests: an application of the confirmative factor analysis in stabilized schizophrenia patients","volume":"25","author":"Noh","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib16","series-title":"MATRICS Consensus Cognitive Battery Manual","author":"Nuechterlein","year":"2006"},{"key":"10.1016\/j.euroneuro.2014.06.009_bib17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3928\/0048-5713-19961201-08","article-title":"Researching the caregiver: family members who care for older psychotic patients","volume":"26","author":"Patterson","year":"1996","journal-title":"Psychiatr. Ann."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.schres.2011.05.003","article-title":"Assessing everyday functioning in schizophrenia: not all informants seem equally informative","volume":"131","author":"Sabbag","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.06.009_bib19","series-title":"A Compendium of Neuropsychological Tests","author":"Spreen","year":"1998"},{"key":"10.1016\/j.euroneuro.2014.06.009_bib20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/schbul\/sbs001","article-title":"The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition","volume":"39","author":"Ventura","year":"2013","journal-title":"Schizophr. Bull."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14001771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14001771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:51:11Z","timestamp":1760377871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14001771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0924977X14001771"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.06.009","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}